×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Session 0702 Safety Evaluation of New Types of Antibodies
Session Chair(s)
Jufeng Wang
Director
National Institutes for Food and Drug Control, China
Speaker(s)
Current Challenges and Opportunities in Preclinical Safety Assessment of Multi-specific Biologics
Hong Wang
Genentech, a Member of Roche Group, China
Senior Scientist/Oncology Therapeutic Area Leader
Yan Huo
CFDA, China
Director of General Toxicology, NCSED
Preclinical Development for Monoclonal Antibody (mAb) Current Practice and Future Direction
James Yan
Covance, China
Executive Director & Site Lead
Have an account?